[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NL960001I1 - Therapeutische nucleosiden. - Google Patents

Therapeutische nucleosiden.

Info

Publication number
NL960001I1
NL960001I1 NL960001C NL960001C NL960001I1 NL 960001 I1 NL960001 I1 NL 960001I1 NL 960001 C NL960001 C NL 960001C NL 960001 C NL960001 C NL 960001C NL 960001 I1 NL960001 I1 NL 960001I1
Authority
NL
Netherlands
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
Prior art date
Application number
NL960001C
Other languages
English (en)
Other versions
NL960001I2 (nl
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL960001(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878719367A external-priority patent/GB8719367D0/en
Priority claimed from GB878725939A external-priority patent/GB8725939D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL960001I1 publication Critical patent/NL960001I1/nl
Publication of NL960001I2 publication Critical patent/NL960001I2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NL960001C 1987-08-15 1996-01-18 Therapeutische nucleosiden. NL960001I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719367A GB8719367D0 (en) 1987-08-15 1987-08-15 Therapeutic compounds
GB878725939A GB8725939D0 (en) 1987-11-05 1987-11-05 Therapeutic compounds

Publications (2)

Publication Number Publication Date
NL960001I1 true NL960001I1 (nl) 1996-03-01
NL960001I2 NL960001I2 (nl) 1996-11-01

Family

ID=26292613

Family Applications (1)

Application Number Title Priority Date Filing Date
NL960001C NL960001I2 (nl) 1987-08-15 1996-01-18 Therapeutische nucleosiden.

Country Status (30)

Country Link
EP (2) EP0308065B1 (nl)
JP (2) JPH0662623B2 (nl)
KR (2) KR960002849B1 (nl)
CN (1) CN1033701C (nl)
AP (2) AP160A (nl)
AT (1) ATE138660T1 (nl)
AU (1) AU612393C (nl)
CS (1) CS276903B6 (nl)
CY (1) CY1833A (nl)
DE (1) DE3855333T2 (nl)
DK (2) DK170045B1 (nl)
ES (1) ES2087639T3 (nl)
FI (1) FI89713C (nl)
GR (1) GR3020372T3 (nl)
HU (1) HU201071B (nl)
IE (1) IE65551B1 (nl)
IL (1) IL87434A (nl)
LU (1) LU88746I2 (nl)
LV (1) LV5264A3 (nl)
MC (1) MC1968A1 (nl)
MX (1) MX9203418A (nl)
MY (1) MY103760A (nl)
NL (1) NL960001I2 (nl)
NO (2) NO167805C (nl)
NZ (1) NZ225809A (nl)
PL (1) PL158285B1 (nl)
PT (1) PT88261B (nl)
SA (1) SA95160244B1 (nl)
SG (1) SG26346G (nl)
SU (1) SU1634138A3 (nl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JP2788084B2 (ja) * 1988-12-19 1998-08-20 ザ ウエルカム フアウンデーシヨン リミテツド 抗ウイルス化合物
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
ATE199719T1 (de) * 1993-06-10 2001-03-15 Rolabo Sl Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (nl) * 1993-11-18 1996-08-01 Ajinomoto Kk
EP0665229B1 (en) * 1994-02-01 1999-11-17 Ajinomoto Co., Inc. Process for the production of nucleic acid base derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501142D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Compounds for use in medicine
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
DE69726255T2 (de) * 1996-01-19 2004-08-26 Glaxo Group Ltd., Greenford Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
ATE222909T1 (de) * 1996-01-26 2002-09-15 Hoffmann La Roche Verfahren zur herstellung von purin-derivaten
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
AU5495898A (en) * 1997-01-17 1998-08-07 Ajinomoto Co., Inc. Novel z-valacyclovir crystals
AU4007699A (en) * 1998-05-21 1999-12-06 Mark Anderson A method for stimulation of defensin production by exposure to isoleucin
WO2003022209A2 (en) * 2001-09-07 2003-03-20 Teva Pharmaceutical Industries Ltd. Crystalline forms of valacyclovir hydrochloride
EP1517678A2 (en) 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
CN1309732C (zh) * 2002-10-28 2007-04-11 南京长澳医药科技有限公司 6-烷氧基-2’,3’-双脱氧鸟嘌呤核苷的制备方法
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
KR20060117355A (ko) * 2004-01-21 2006-11-16 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로버 염산염의 제조 방법
GB2413017A (en) * 2004-04-06 2005-10-12 Ford Global Tech Llc An electrical connector for a vehicle
WO2006035452A1 (en) * 2004-09-27 2006-04-06 Matrix Laboratories Ltd Novel pseudomorph of valaciclovir hydrochloride
ES2379804T3 (es) 2005-05-25 2012-05-03 Eli Lilly And Company Ésteres de ciclopropanocarboxilato de aciclovir
EP1746098A1 (en) 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
CN101456859B (zh) * 2009-01-06 2011-07-20 华南理工大学 抗病毒药物缬昔洛韦的制备方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN102850354B (zh) * 2012-10-10 2014-07-23 山东金城医药化工股份有限公司 高纯度cbz-万乃洛韦的制备方法
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
RU2750867C1 (ru) * 2020-05-18 2021-07-05 Александр Сергеевич Самойлов Производные гуанина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
DE3534774A1 (de) * 1985-09-30 1987-04-02 Robugen Gmbh Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
DK451388A (da) 1989-02-16
DK82694A (da) 1994-07-08
DK451388D0 (da) 1988-08-12
NO883612L (no) 1989-02-16
EP0308065B1 (en) 1995-01-04
NO167805B (no) 1991-09-02
DE3855333D1 (de) 1996-07-04
HU201071B (en) 1990-09-28
FI89713B (fi) 1993-07-30
JPH03115284A (ja) 1991-05-16
AU612393B2 (en) 1991-07-11
MY103760A (en) 1993-09-30
SU1634138A3 (ru) 1991-03-07
AU2097888A (en) 1989-02-16
DK170045B1 (da) 1995-05-08
JPS6468373A (en) 1989-03-14
MX9203418A (es) 1992-07-01
FI89713C (fi) 1993-11-10
JPH07113025B2 (ja) 1995-12-06
CN1032538A (zh) 1989-04-26
NO883612D0 (no) 1988-08-12
EP0308065A3 (en) 1989-09-27
GR3020372T3 (en) 1996-09-30
JPH0662623B2 (ja) 1994-08-17
EP0596542A1 (en) 1994-05-11
SA95160244B1 (ar) 2006-10-02
PL158285B1 (en) 1992-08-31
PT88261A (pt) 1989-06-30
AP8800099A0 (en) 1988-08-01
CS276903B6 (en) 1992-09-16
NZ225809A (en) 1991-07-26
IE882463L (en) 1989-02-15
IL87434A (en) 1993-06-10
LU88746I2 (fr) 1996-10-04
EP0308065A2 (en) 1989-03-22
MC1968A1 (fr) 1989-09-29
NO1996015I1 (no) 1996-12-17
HUT47935A (en) 1989-04-28
CN1033701C (zh) 1997-01-01
NL960001I2 (nl) 1996-11-01
PL274215A1 (en) 1990-02-19
IE65551B1 (en) 1995-11-01
CY1833A (en) 1995-12-01
KR890003761A (ko) 1989-04-17
FI883757A0 (fi) 1988-08-12
KR960002849B1 (ko) 1996-02-27
ES2087639T3 (es) 1996-07-16
DK170803B1 (da) 1996-01-22
AU612393C (en) 2006-08-17
FI883757A (fi) 1989-02-16
CS8805594A2 (en) 1990-06-13
AP160A (en) 1991-11-18
PT88261B (pt) 1995-03-01
LV5264A3 (lv) 1993-10-10
ATE138660T1 (de) 1996-06-15
IL87434A0 (en) 1989-01-31
NO167805C (no) 1991-12-11
SG26346G (en) 1995-09-01
KR960004940B1 (ko) 1996-04-18
DE3855333T2 (de) 1996-12-05
EP0596542B1 (en) 1996-05-29
AP55A (en) 1989-09-26

Similar Documents

Publication Publication Date Title
MX9203418A (es) Nucleosidos terapeuticos.
DE3852682D1 (de) Therapeutische Nucleoside.
MX9203215A (es) Nucleosidos terapeuticos.
ATE116984T1 (de) Therapeutische nukleoside.
DK564088D0 (da) Nukleosidderivater
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
FI875039A (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
DE3788873D1 (de) Massagegerät.
MX9203420A (es) Nucleosidos terapeuticos.
DK140588D0 (da) Terapeutisk nucleosider
ATE77386T1 (de) Therapeutische nucleoside.
DK725088A (da) Terapeutiske nucleosider
FI871028A (fi) Slirskydd med kombinationsstomme foer fordonsdaeck.
ATE104675T1 (de) Therapeutische nucleoside.
ES1003952Y (es) Pulsera terapeutica.
FI870526A0 (fi) Trevaegsventil med gummislang.
FI870853A0 (fi) Torkstaellning med flaekt.
FI872522A0 (fi) Engaongsmadrass med byxor.
FI872111A0 (fi) Roejningssaog med kedjesaogsanordning.
FI870144A0 (fi) Uppvaermningsanordning med staolplaotskonstruktion.
FI872070A0 (fi) Elmotor med vaexel.
FI871473A0 (fi) Traeflishuggningsmaskin med dubbla trummor.
FI872023A0 (fi) Skida med justerbar styvhet.